Aptose Biosciences Inc (APS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 05-2014 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 22 | 22 | 19 | 9 | 7 |
| Accounts payable and accrued liabilities | 281 | -10 | -325 | 235 | 324 |
| Other Working Capital | 125 | 539 | -911 | 362 | -190 |
| Other Operating Activity | -2,816 | -2,462 | -2,244 | -2,360 | -3,760 |
| Operating Cash Flow | $-2,389 | $-1,912 | $-3,461 | $-1,753 | $-3,618 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -41 | -39 | -83 | -86 | -13 |
| Purchase Of Investment | N/A | -30 | N/A | -50 | -10,155 |
| Sale Of Investment | -222 | N/A | 6,508 | N/A | N/A |
| Other Investing Activity | 33 | 42 | 59 | 82 | 56 |
| Investing Cash Flow | $-230 | $-27 | $6,483 | $-54 | $-10,112 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | 0 | N/A | -984 |
| Common Stock Issued | 0 | 7 | 0 | 0 | 23,578 |
| Other Financing Activity | 58 | 26 | 221 | 437 | 2,324 |
| Financing Cash Flow | $57 | $34 | $221 | $437 | $24,918 |
| Exchange Rate Effect | -84 | 492 | 314 | N/A | -3 |
| Beginning Cash Position | 11,283 | 12,696 | 10,173 | 11,331 | 6,663 |
| End Cash Position | 8,289 | 11,283 | 13,731 | 9,961 | 17,848 |
| Net Cash Flow | $-2,561 | $-1,905 | $3,243 | $-1,370 | $11,188 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,389 | -1,912 | -3,461 | -1,753 | -3,618 |
| Capital Expenditure | -41 | -39 | -83 | -86 | -13 |
| Free Cash Flow | -2,430 | -1,951 | -3,544 | -1,839 | -3,631 |